Skip to main content

Peer Review reports

From: Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

Original Submission
15 Jun 2009 Submitted Original manuscript
1 Sep 2009 Reviewed Reviewer Report - Piero Almasio
24 Nov 2009 Reviewed Reviewer Report - John Kalbfleisch
Resubmission - Version 2
Submitted Manuscript version 2
11 Dec 2009 Reviewed Reviewer Report - Piero Almasio
26 Dec 2009 Author responded Author comments - Adriano M Pellicelli
Resubmission - Version 3
26 Dec 2009 Submitted Manuscript version 3
23 Jan 2010 Author responded Author comments - Adriano M Pellicelli
Resubmission - Version 4
23 Jan 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
17 Feb 2010 Author responded Author comments - Adriano M Pellicelli
Resubmission - Version 8
17 Feb 2010 Submitted Manuscript version 8
Publishing
19 Feb 2010 Editorially accepted
19 Feb 2010 Article published 10.1186/1471-230X-10-21

You can find further information about peer review here.

Back to article page